Home › Research › End-of-life care
Public Preferences for End-of-Life Timing in Alzheimer Disease and Related Dementias
Dennelly L, Thomas Z, McAndrew T, Davis DS.. medRxiv, 2026-07-29
Topic: Health services, long-term care and technology
Plain-language summary
We found that 75% of participants would choose for their life to end in the early stages of ADRD. Factors associated with a hope of later ADRD stages were race (OR = 1.9; 95CI = [1.1, 3.3]; p = 0.02; Black vs White, Non-hispanic) and education level (OR = 2.7; 95CI = [1.2, 5.7]; p = 0.01; Less than high school vs College). This preference is associated with race and education level. Meaning These results demonstrate that, despite clinical focus on longevity, a generalist patient population may hope to end life sooner.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dennelly, L., Thomas, Z., McAndrew, T., & Davis, D. S. (2026). Public Preferences for End-of-Life Timing in Alzheimer Disease and Related Dementias. medRxiv. https://doi.org/10.64898/2026.07.25.26358937
Vancouver
Dennelly L, Thomas Z, McAndrew T, Davis DS. Public Preferences for End-of-Life Timing in Alzheimer Disease and Related Dementias. medRxiv. 2026. doi:10.64898/2026.07.25.26358937.
BibTeX
@article{dennelly2026-233672c6,
author = {Dennelly, L. and Thomas, Z. and McAndrew, T. and Davis, D. S.},
title = {{Public Preferences for End-of-Life Timing in Alzheimer Disease and Related Dementias}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.07.25.26358937},
url = {https://doi.org/10.64898/2026.07.25.26358937}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We found that 75% of participants would choose for their life to end in the early stages of ADRD.
- Factors associated with a hope of later ADRD stages were race (OR = 1.9; 95CI = [1.1, 3.3]; p = 0.02; Black vs White, Non-hispanic) and education level (OR = 2.7; 95CI = [1.2, 5.7]; p = 0.01; Less than high school vs College).
- This preference is associated with race and education level.
- Meaning These results demonstrate that, despite clinical focus on longevity, a generalist patient population may hope to end life sooner.
Study details
- Participants1,015
- Effect sizeOR = 1.9; OR = 2.7
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 35 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 22 of the 62 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,015 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 22 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 22 of the 62 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in End-of-life care from nearby years
Also in End-of-life care
116 studies in the library are filed under End-of-life care with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The End-of-life care hub.